Liminal BioSciences Inc. of LAVAL, A8, a company, filed a Form D exempt-offering notice with the SEC on 2020-11-18. The offering totals $30.0M, of which $30.0M was reported sold. Industry: Biotechnology.
Showing 25 of 26 people.
| Name | Role | Location |
|---|---|---|
| Simon G Best | Director | Laval, A8 |
| Gary J Bridger | Director | BOSTON, MA |
| Neil A Klompas | Director | West Vancouver, A1 |
| Alek A Krstajic | Director | Laval, A8 |
| Eugene A Siklos | Director | Laval, A8 |
| Timothy Steven Wach | Director | Laval, A8 |
| Moira Daniels | Executive Officer | Cambridge, X0 |
| Marie Iskra | Executive Officer | Laval, A8 |
| Martin Leclerc | Executive Officer | Laval, A8 |
| Murielle Lortie | Executive Officer | Laval, A8 |
| Bruce Pritchard | Executive Officer | Cambridge, X0 |
| Patrick Sartore | Executive Officer | Laval, A8 |
| Timothy Victor Wach | Director | Laval, A8 |
| Martin Victor Leclerc | Executive Officer | Laval, A8 |
| John Victor Moran | Executive Officer | Laval, A8 |
| Patrick Victor Santore | Executive Officer | Laval, A8 |
| Bruce Victor Pritchard | Executive Officer | Laval, A8 |
| Neil Victor Klompas | Director | Laval, A8 |
| Gary Victor Bridger | Director | Laval, A8 |
| Charles Victor Kenworthy | Director | Laval, A8 |
| Zachary Victor Newton | Director | Laval, A8 |
| Paul Victor Mesburis | Director | Laval, A8 |
| Kenneth Victor Galbraith | Director | Laval, A8 |
| Kenneth Victor Galbraith | Executive Officer | Laval, A8 |
| Simon Victor Best | Director | Laval, A8 |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2019-06-24 | D | $37.1M | $37.1M |